Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Yale University
M.D. Anderson Cancer Center
Mayo Clinic
University of Alabama at Birmingham
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Columbia University
Fondazione Italiana Linfomi - ETS
Institute of Hematology & Blood Diseases Hospital, China
Columbia University
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Assistance Publique - Hôpitaux de Paris
Columbia University
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Fondazione Italiana Linfomi - ETS
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Centre for Human Drug Research, Netherlands
Beijing GoBroad Hospital
Case Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Beijing GoBroad Hospital
Thomas Jefferson University
City of Hope Medical Center
Instituto de Investigación Biomédica de Salamanca
Tianjin Medical University Cancer Institute and Hospital
Fox Chase Cancer Center
City of Hope Medical Center
Yale University